Page last updated: 2024-08-21

cyclopentane and Lymphoma

cyclopentane has been researched along with Lymphoma in 8 studies

Research

Studies (8)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (12.50)	18.7374
1990's	1 (12.50)	18.2507
2000's	1 (12.50)	29.6817
2010's	4 (50.00)	24.3611
2020's	1 (12.50)	2.80

Authors

Authors	Studies
Berger, A; Chen, C; Danilov, AV; Hernandez-Ilizaliturri, F; Kambhampati, S; Lam, V; Pennock, N; Rodriguez-Rodriguez, S; Roleder, C; Siddiqi, T; Torka, P; Vuong, D; Wang, JH; Wang, L; Wang, X; Xia, Z	1
Chu, Y; Jeong, LS; Jia, L; Liu, J; Luo, Z; Pan, Y; Wang, W; Wang, Y; Zhou, X	1
Berger, AJ; Dezube, BJ; Diefenbach, C; Faessel, HM; Harvey, RD; Hua, Z; Jakubowiak, AJ; Kelly, K; Lebovic, D; Lonial, S; Mulligan, G; O'Connor, OA; Orlowski, RZ; Shah, JJ; Smith, MR; Tirrell, S	1
Furuta, K; Hirabayashi, Y; Isobe, R; Ito, T; Kaneko, N; Kawakami, F; Kawakami, T; Kitano, K; Mimura, Y; Nakazawa, H; Shimazaki, M	1
Germanos, MS; Manfredi, MG; Robertson, R; Silva, MD; Smith, PG	1
Fingrut, O; Flescher, E	1
Hallett, W; Heidelberger, C; Kundu, NG; Perlman, KL; Wright, JA	1
Grillo, FG; Hudson, TH	1

Trials

1 trial(s) available for cyclopentane and Lymphoma

Article	Year
Phase I Study of the Novel Investigational NEDD8-Activating Enzyme Inhibitor Pevonedistat (MLN4924) in Patients with Relapsed/Refractory Multiple Myeloma or Lymphoma. Clinical cancer research : an official journal of the American Association for Cancer Research, 2016, Jan-01, Volume: 22, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Biomarkers; Cyclopentanes; Drug Administration Schedule; Drug Monitoring; Drug Resistance, Neoplasm; Female; Humans; Lymphoma; Male; Maximum Tolerated Dose; Middle Aged; Molecular Targeted Therapy; Multiple Myeloma; NEDD8 Protein; Neoplasm Recurrence, Local; Pyrimidines; Retreatment; Treatment Outcome; Ubiquitins	2016

Article

Year

Phase I Study of the Novel Investigational NEDD8-Activating Enzyme Inhibitor Pevonedistat (MLN4924) in Patients with Relapsed/Refractory Multiple Myeloma or Lymphoma.

Clinical cancer research : an official journal of the American Association for Cancer Research, 2016, Jan-01, Volume: 22, Issue:1

Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Biomarkers; Cyclopentanes; Drug Administration Schedule; Drug Monitoring; Drug Resistance, Neoplasm; Female; Humans; Lymphoma; Male; Maximum Tolerated Dose; Middle Aged; Molecular Targeted Therapy; Multiple Myeloma; NEDD8 Protein; Neoplasm Recurrence, Local; Pyrimidines; Retreatment; Treatment Outcome; Ubiquitins

2016

Other Studies

7 other study(ies) available for cyclopentane and Lymphoma

Article	Year
Pharmacologic targeting of Nedd8-activating enzyme reinvigorates T-cell responses in lymphoid neoplasia. Leukemia, 2023, Volume: 37, Issue:6 Topics: Antineoplastic Agents; CD8-Positive T-Lymphocytes; Cell Line, Tumor; Cyclopentanes; Humans; Lymphoma; NEDD8 Protein; Tumor Microenvironment; Ubiquitin-Conjugating Enzymes	2023
Targeting protein neddylation with an NEDD8-activating enzyme inhibitor MLN4924 induced apoptosis or senescence in human lymphoma cells. Cancer biology & therapy, 2015, Volume: 16, Issue:3 Topics: Apoptosis; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cellular Senescence; Cullin Proteins; Cyclopentanes; Gene Expression Regulation, Leukemic; Humans; Lymphoma; NEDD8 Protein; Protein Processing, Post-Translational; Pyrimidines; Signal Transduction; Ubiquitin-Protein Ligases; Ubiquitins	2015
Persistent Infection of Drug-resistant Influenza A Virus during Chemotherapy for Malignant Lymphoma. Internal medicine (Tokyo, Japan), 2016, Volume: 55, Issue:13 Topics: Acids, Carbocyclic; Aged, 80 and over; Antiviral Agents; Cyclopentanes; Drug Resistance, Viral; Guanidines; Humans; Influenza A Virus, H3N2 Subtype; Influenza, Human; Lymphoma; Male; Mutation; Neuraminidase; Oseltamivir	2016
Multimodal imaging with (18)F-FDG PET and Cerenkov luminescence imaging after MLN4924 treatment in a human lymphoma xenograft model. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2011, Volume: 52, Issue:11 Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Transformation, Neoplastic; Cyclopentanes; Female; Fluorodeoxyglucose F18; Humans; Luminescent Measurements; Lymphoma; Mice; Molecular Imaging; Positron-Emission Tomography; Pyrimidines	2011
Plant stress hormones suppress the proliferation and induce apoptosis in human cancer cells. Leukemia, 2002, Volume: 16, Issue:4 Topics: Acetates; Animals; Apoptosis; Caspase 3; Caspases; Cell Cycle; Cell Division; Cyclopentanes; Dose-Response Relationship, Drug; Humans; Leukemia, T-Cell; Lymphoma; Male; Mice; Mice, Inbred C57BL; Oxylipins; Plant Growth Regulators; Tumor Cells, Cultured	2002
Cyclopenta[f]isoquinoline derivatives designed to bind specifically to native deoxyribonucleic acid. 1. Synthesis of 3-ethoxy-8-methyl-7(5)H-cyclopenta[f]isoquinoline. Journal of medicinal chemistry, 1975, Volume: 18, Issue:4 Topics: Binding Sites; Cells, Cultured; Cyclopentanes; DNA; HeLa Cells; Isoquinolines; Lymphoma; Magnetic Resonance Spectroscopy; Models, Structural; Neoplasms, Experimental; Nucleic Acid Conformation; Spectrophotometry, Ultraviolet	1975
Brefeldin-A enhancement of ricin A-chain immunotoxins and blockade of intact ricin, modeccin, and abrin. The Journal of biological chemistry, 1991, Oct-05, Volume: 266, Issue:28 Topics: Abrin; Antitoxins; Biological Transport; Brefeldin A; Cyclopentanes; Drug Interactions; Golgi Apparatus; Humans; Immunotoxins; Interleukin-2; Kinetics; Lectins; Lymphoma; Plant Lectins; Ribosome Inactivating Proteins, Type 2; Ricin; Toxins, Biological; Tumor Cells, Cultured	1991